Banik I - Search Results

1

MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth.

Wilms C, Kroeger CM, Hainzl AV, Banik I, Bruno C, Krikki I, Farsam V, Wlaschek M, Gatzka MV. Wilms C, et al. Among authors: banik i. Oncotarget. 2017 Jun 27;8(40):67287-67299. doi: 10.18632/oncotarget.18617. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978033 Free PMC article.

2

P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma.

Banik I, Ghosh A, Beebe E, Burja B, Frank Bertoncelj M, Dooley CM, Markkanen E, Dummer R, Busch-Nentwich EM, Levesque MP. Banik I, et al. Cancers (Basel). 2023 Jan 31;15(3):877. doi: 10.3390/cancers15030877. Cancers (Basel). 2023. PMID: 36765834 Free PMC article.

3

NRAS^Q61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells.

Banik I, Cheng PF, Dooley CM, Travnickova J, Merteroglu M, Dummer R, Patton EE, Busch-Nentwich EM, Levesque MP. Banik I, et al. Pigment Cell Melanoma Res. 2021 Mar;34(2):150-162. doi: 10.1111/pcmr.12925. Epub 2020 Sep 24. Pigment Cell Melanoma Res. 2021. PMID: 32910840

4

The genetic evolution of acral melanoma.

Wang M, Fukushima S, Sheen YS, Ramelyte E, Pacheco NC, Shi C, Liu S, Banik I, Aquino JD, Acosta MS, Levesque M, Dummer R, Liau JY, Chu CY, Shain AH, Yeh I, Bastian BC. Wang M, et al. Among authors: banik i. bioRxiv [Preprint]. 2023 Oct 19:2023.10.18.562802. doi: 10.1101/2023.10.18.562802. bioRxiv. 2023. PMID: 37904969 Free PMC article. Preprint.

5

Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.

Wang M, Banik I, Shain AH, Yeh I, Bastian BC. Wang M, et al. Among authors: banik i. Genome Med. 2022 Jun 16;14(1):65. doi: 10.1186/s13073-022-01068-0. Genome Med. 2022. PMID: 35706047 Free PMC article.

6

Does the galaxy NGC1052-DF2 falsify Milgromian dynamics?

Kroupa P, Haghi H, Javanmardi B, Zonoozi AH, Müller O, Banik I, Wu X, Zhao H, Dabringhausen J. Kroupa P, et al. Among authors: banik i. Nature. 2018 Sep;561(7722):E4-E5. doi: 10.1038/s41586-018-0429-z. Epub 2018 Sep 12. Nature. 2018. PMID: 30209364 No abstract available.

7

Asymmetric synthesis of anticancer beta-lactams via Staudinger reaction: utilization of chiral ketene from carbohydrate.

Banik BK, Banik I, Becker FF. Banik BK, et al. Among authors: banik i. Eur J Med Chem. 2010 Feb;45(2):846-8. doi: 10.1016/j.ejmech.2009.11.024. Epub 2009 Nov 18. Eur J Med Chem. 2010. PMID: 19962794

8

Stereocontrolled synthesis of anticancer beta-lactams via the Staudinger reaction.

Banik BK, Banik I, Becker FF. Banik BK, et al. Among authors: banik i. Bioorg Med Chem. 2005 Jun 1;13(11):3611-22. doi: 10.1016/j.bmc.2005.03.044. Bioorg Med Chem. 2005. PMID: 15862989

9

Synthesis of anticancer beta-lactams: mechanism of action.

Banik BK, Becker FF, Banik I. Banik BK, et al. Among authors: banik i. Bioorg Med Chem. 2004 May 15;12(10):2523-8. doi: 10.1016/j.bmc.2004.03.033. Bioorg Med Chem. 2004. PMID: 15110834

10

Simple synthesis of substituted pyrroles.

Banik BK, Samajdar S, Banik I. Banik BK, et al. Among authors: banik i. J Org Chem. 2004 Jan 9;69(1):213-6. doi: 10.1021/jo035200i. J Org Chem. 2004. PMID: 14703403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page